Health Catalyst (NASDAQ:HCAT) Posts Earnings Results, Misses Estimates By $0.09 EPS

Health Catalyst (NASDAQ:HCAT) announced its quarterly earnings results on Monday. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.09), Zacks reports. Health Catalyst had a negative net margin of 31.67% and a negative return on equity of 7.21%. Health Catalyst updated its FY 2025 guidance to EPS and its Q4 2025 guidance to EPS.

Health Catalyst Trading Up 0.7%

Shares of HCAT stock traded up $0.02 on Monday, reaching $2.85. 992,937 shares of the stock were exchanged, compared to its average volume of 693,076. The firm has a 50 day moving average of $3.05 and a two-hundred day moving average of $3.52. The stock has a market cap of $200.55 million, a P/E ratio of -1.89 and a beta of 1.64. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.44. Health Catalyst has a 1-year low of $2.52 and a 1-year high of $9.24.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. First Light Asset Management LLC boosted its holdings in Health Catalyst by 17.2% in the 2nd quarter. First Light Asset Management LLC now owns 12,230,181 shares of the company’s stock worth $46,108,000 after acquiring an additional 1,793,374 shares during the period. Geode Capital Management LLC boosted its position in Health Catalyst by 11.4% in the 2nd quarter. Geode Capital Management LLC now owns 1,662,455 shares of the company’s stock valued at $6,269,000 after buying an additional 169,580 shares during the last quarter. AQR Capital Management LLC increased its position in shares of Health Catalyst by 816.8% during the first quarter. AQR Capital Management LLC now owns 168,344 shares of the company’s stock worth $763,000 after acquiring an additional 149,981 shares during the last quarter. Vanguard Group Inc. lifted its stake in shares of Health Catalyst by 2.9% in the third quarter. Vanguard Group Inc. now owns 4,295,691 shares of the company’s stock worth $12,243,000 after acquiring an additional 119,117 shares in the last quarter. Finally, Qube Research & Technologies Ltd boosted its holdings in Health Catalyst by 68.4% in the second quarter. Qube Research & Technologies Ltd now owns 282,281 shares of the company’s stock valued at $1,064,000 after purchasing an additional 114,626 shares during the last quarter. Institutional investors and hedge funds own 85.00% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Evercore ISI dropped their price target on Health Catalyst from $4.00 to $3.00 and set an “in-line” rating for the company in a research report on Wednesday, October 8th. Weiss Ratings reissued a “sell (d-)” rating on shares of Health Catalyst in a research report on Wednesday, October 8th. BTIG Research reissued a “neutral” rating on shares of Health Catalyst in a research note on Friday, September 5th. Wells Fargo & Company decreased their price target on shares of Health Catalyst from $10.00 to $6.00 and set an “overweight” rating on the stock in a research note on Monday, August 11th. Finally, KeyCorp cut their price objective on shares of Health Catalyst from $5.00 to $4.00 and set an “overweight” rating for the company in a research report on Wednesday, October 8th. Three research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $4.55.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.